PCN332 - REAL-WORLD USAGE OF BORTEZOMIB IN COMBINATION WITH THALIDOMIDE AND DEXAMETHASONE (VTD) AS FRONTLINE (FL) TREATMENT IN STEM CELL TRANSPLANT (SCT) ELIGIBLE MULTIPLE MYELOMA (MM) PATIENTS ACROSS EU5 COUNTRIES
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.414
https://www.valueinhealthjournal.com/article/S1098-3015(18)33714-8/fulltext
Section Title :
Section Order :
2317
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33714-8&doi=10.1016/j.jval.2018.09.414